Medicine and Dentistry
Cohort Analysis
100%
Acute Myeloid Leukemia
91%
Acute Leukemia
31%
Myelodysplastic Syndrome
30%
Anemia
30%
Hazard Ratio
28%
General Medicine
23%
Overall Survival
20%
Acute Promyelocytic Leukemia
20%
Intensive Care Unit
20%
Case-Control Study
20%
Malignant Neoplasm
18%
Proportional Hazards Model
14%
Odds Ratio
14%
Diagnosis
12%
De Novo Acute Myeloid Leukemia
12%
Cohort Effect
12%
Observational Study
12%
Infection
12%
Autoimmune Disease
12%
Allogeneic Stem Cell Transplantation
12%
Secondary Acute Myeloid Leukemia
12%
Recurrence Free Survival
11%
Blood Transfusion
10%
Antibiotics
10%
Health Care
10%
Venous Thromboembolism
10%
Cancer Treatment
10%
Clinical Significance
10%
Cancer Risk
10%
Monocytosis
10%
Hematological Procedure
10%
Nonsteroid Antiinflammatory Agent
10%
Myeloproliferative Neoplasm
10%
Logistic Regression Analysis
8%
Disease
8%
Tretinoin
8%
Acute Lymphoblastic Leukemia
8%
Allogeneic Hematopoietic Stem Cell Transplantation
7%
Mortality Rate
7%
Intensive Care
7%
Blood Product
6%
Leukemia
6%
Sulfhemoglobinemia
5%
Spontaneous Remission
5%
Population
5%
Socioeconomic Status
5%
Platelet
5%
Survival Analysis
5%
Blood Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
71%
Cohort Study
70%
Chemotherapy
31%
Myelodysplastic Syndrome
30%
Acute Leukemia
24%
Malignant Neoplasm
23%
Remission
22%
Case-Control Study
20%
Promyelocytic Leukemia
20%
Disease
16%
De Novo Acute Myeloid Leukemia
16%
Clinical Trial
14%
Comorbidity
13%
Secondary Acute Myeloid Leukemia
13%
Autoimmune Disease
12%
Infection
12%
Retinoic Acid
11%
Mortality Rate
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Antibiotic Agent
10%
Venous Thromboembolism
10%
Anemia
10%
Hodgkin Disease
10%
Myeloproliferative Neoplasm
10%
Acute Lymphoblastic Leukemia
8%
Leukemia
7%
Overall Survival
5%
Psychotropic Agent
5%